Lv1
40 积分 2023-03-17 加入
FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma
2天前
已完结
British Association of Sexual Health and HIV UK national guideline for the management of anogenital herpes, 2024
1个月前
已完结
Asia‐Pacific consensus recommendations on the management of generalized pustular psoriasis
1个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
4个月前
已完结
度普利尤单抗治疗中重度特应性皮炎的长期疗效及安全性
6个月前
已完结
中国肿瘤化疗相关性血小板减少症专家诊疗共识
11个月前
已完结
免疫检查点抑制剂相关毒性防治与管理建议
11个月前
已完结
Cortico-limbic circuitry and the airways: Insights from functional neuroimaging of respiratory afferents and efferents
11个月前
已完结
Association Between Age and Survival Trends in Advanced Non–Small Cell Lung Cancer After Adoption of Immunotherapy
1年前
已完结
皖公网安备34019202002308
